Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EY5456 / 1||- / -|
Administered by: Other Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021657675
Write-up: Fainting; This is a spontaneous report from a contactable pharmacist received from the Agency Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202106041350201580-SAP3P, Safety Report Unique Identifier GB-MHRA-ADR 25420610. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 04Jun2021 (Lot Number: EY5456) as single dose for COVID-19 immunisation. The patient medical history was not reported. Patient had not symptoms associated with COVID-19 or had not a COVID-19 test. The patient''s concomitant medications were not reported. The patient experienced fainting on 04Jun2021. Event outcome was recovered on 04Jun2021. No follow-up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166